Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 25, 2020, titled "Dr. Reddy's announces the launch of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection in the U.S. Market".
Press Release Sep 25 2020
Filed with NSE ·
Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call · Replay · Jul 22Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings CallDr. Reddy's Laboratories' next earnings callDr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call · Oct 23, 2026 at 10:00 AM EDTRegister
6ix hasn’t read this filing yet.
Dr. Reddy's Laboratories Ltd. on 6ix
Earlier from Dr. Reddy's Laboratories
- Press Release Sep 17 2020
- Press Release Sep 16 2020
- Press Release Sep 09 2020
- Press Release Sep 07 2020
- Press Release Sep 03 2020
Later from Dr. Reddy's Laboratories
- Press Release Sep 26 2020
- Press Release Oct 01 2020
- Press Release Oct 03 2020
- Press Release Oct 05 2020
- Press Release Oct 12 2020
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories